Skip to content
healthcare.dev
Get a free key

OZEMPIC

NDC 0169-1704, oral semaglutide, tablet, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-1704
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213051
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1704 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SEMAGLUTIDE4 mg/1

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package
0169-1704-300016917043030 TABLET in 1 BOTTLE, PLASTIC (0169-1704-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27f15fac-7d98-4114-a2ec-92494a91da98

  • NADAC price for package 00169170430

    GET /v1/drugs/nadac/00169170430

Use it

Look up 0169-1704 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1704 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-1704. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.